CIDRAP newsletters options
Half of patients hospitalized with severe COVID-19 across 302 UK hospitals developed one or more health complications within 28 days or discharge, according to a study yesterday in The Lancet.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A multicomponent intervention implemented at nursing homes in Michigan significantly reduced the prevalence of multidrug-resistant organisms (MDROs) in residents' rooms, according to the results of a randomized clinical trial reported today in JAMA Network Open.
Misinformation has led people to avoid effective approaches, causing avoidable illnesses and death, he says.
The drug was not tied to faster recovery, but the regimen might be why.
About 23 million kids missed their basic vaccines in 2020.
New data presented today indicate that a shorter treatment regimen for highly drug-resistant forms of tuberculosis (TB) remains highly effective with reduced doses of one of its components.
Yesterday in the New England Journal of Medicine results from a phase 3 trial showed that a combination of bamlanivimab plus etesevimab monoclonal antibodies led to a lower incidence of COVID-19–related hospitalization and deaths.
Much of the increase in cases is led by the more transmissible Delta variant, which has now been detected in 111 nations.
Twelve of 20 fast food and casual eateries received an "F" for their sourcing policies.
A video tool increased patient knowledge, desire for more info, and mask acceptance.
The increases come as poll data show 1 in 4 young adults say they are not likely to get the vaccine.
A Wellcome report yesterday says more research is needed on drug-resistant bacterial infections (DRIs), but current data indicate that DRIs can be more likely to occur—and have more serious ramifications—in people with health conditions like cancer or who have received extensive treatment such as surgery.
Half of 399 hospitalized COVID-19 patients developed bacterial infections 48 or more hours after hospitalization, according to a PLOS One study yesterday. The bacterial superinfections were associated most strongly with lung disease, encephalopathy, mechanical ventilation, hospital stay of 8 or more days, and steroid treatment.
Two doses of the vaccine were safe and 78% effective in preventing infection in pregnant women.
There have been 100 cases of a rare neurologic syndrome in 12.8 million US J&J recipients, mostly in men over 50.
The data, from 2011 through 2018, suggest the agency's antibiotic stewardship efforts are having an impact.
The country is ordering oxygen supplies from other nations, enough for home treatment.
Patients in several high-income countries still have limited access to most of the new antibacterials approved since 2010, and as a result sales revenue for these drugs has been insufficient—findings that highlight the poor commercial prospects for new antibiotics, researchers reported yesterday in Clinical Infectious Diseases.
Today a consensus statement by several leading public health organizations and a commentary in the Annals of Internal Medicine voiced support for mandating COVID-19 vaccinations in US healthcare workers (HCWs).
The FDA and the CDC said so far there are not enough data to recommend a booster.
